Skip to main content

Table 2 Comparisons between subjects with and without CHD

From: Effects of low-dose aspirin in subjects with dyslipidemia

Variables CHD(n = 40) Without CHD(n = 162)
Male (%) 23(57.5)* 82(50.6)
Age (years) 55.4 ± 8.7* 51.2 ± 7.3
Smoking (%) 22(55.0)* 74(45.7)
SBP (mmHg) 134.2 ± 14.5 132.6 ± 16.3
DBP (mmHg) 73.5 ± 10.1 71.4 ± 8.6
HR (bpm) 77.3 ± 8.0* 71.4 ± 6.6
W-H ratio 0.90 ± 0.04 0.88 ± 0.05
TC (mmol/L) 5.28 ± 0.23 5.04 ± 0.22
TG (mmol/L) 1.66 ± 0.30 1.59 ± 0.37
LDL (mmol/L) 3.49 ± 0.44* 3.20 ± 0.38
HDL (mmol/L) 0.89 ± 0.17 0.92 ± 0.20
Lp(a) (mg/L) 258.56 ± 30.86* 227.16 ± 24.43
ApoA1 (mmol/L) 1.04 ± 0.27 1.07 ± 0.22
ApoB (mmol/L) 1.15 ± 0.33 1.10 ± 0.29
FPG (mmol/L) 5.5 ± 0.5 5.2 ± 0.6
HbA1c (%) 5.9 ± 0.7 5.6 ± 0.5
Hs-CRP (mg/L) 13.4 ± 3.8* 10.7 ± 3.1
Hypertension (%) 16(40.0)* 38(23.5)
Diabetes (%) 9(22.5)* 20(12.3)
Intracranial hemorrhage (%) 0(0) 0(0)
Gastrointestinal bleeding (%) 3(7.5)* 2(1.2)
HP infection (%) 4(10.0)* 11(6.8)
Statins (%) 37(92.5) 150(92.6)
Anti-hypertension (%) 11(27.5)* 27(16.7)
Anti-diabetes (%) 5(12.5) 18(11.1)
  1. Denote: * P < 0.05 versus without CHD group